Caplin Point Laboratories informs about press release

24 Sep 2021 Evaluate

Caplin Point Laboratories has informed that it enclosed a press release titled ‘Caplin Point's CRO Amaris Clinical completes USFDA audit with nil observations’.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1289.55 -1.65 (-0.13%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.